Amit Bahl

5PUBLICATIONS
20CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 27, 2025
Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9.

Amit Bahl, Andrew Chilelli, Rita Faria

|Aug 27, 2025
Structured Expert Elicitation to Inform Long-Term Survival Extrapolations in Advanced Renal Cell Carcinoma.

Dawn Lee, Zain Ahmad, James M G Larkin

|Aug 01, 2025
Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study.

Amit Bahl, Andrew Chilelli, Rita Faria

|Apr 21, 2025
Attributes and Health Care Resource Utilization of Patients on Enzalutamide or Abiraterone for Metastatic Castration-Resistant Cancer in England.

Amit Bahl, Rita Faria, Axel S Merseburger

|Jul 26, 2021
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease.

Michel Bolla, Anouk Neven, Philippe Maingon

Pageof 1

Frequent Collaborators

3 joint publications

Rita Faria

3 joint publications

Nigel Rozario

2 joint publications

Axel S Merseburger

2 joint publications

Robert Snijder